my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
The new circular RNA enables specific binding and inhibition of heterogeneous nuclear ribonucleoprotein L in cells and thus opens new therapeutic more
Easy setting of standard parameters in screening experiments and direct use in production without further method transfer step more
Immunity testing against Covid-19 without false-positives is possible using the right combi-nation of optimized solutions for ELISA protocol. more
It’s time to act if you are using alkylphenol ethoxylate (APE) surfactants such as nonylphenol ethoxylates (NPEs) and octylphenol ethoxylates (OPEs) more
Can the pharmaceutical industry digitize your processes as quickly as the current competitive situation requires? more
The new circular RNA enables specific binding and inhibition of heterogeneous nuclear ribonucleoprotein L in cells and thus opens new therapeutic more
Easy setting of standard parameters in screening experiments and direct use in production without further method transfer step more
Immunity testing against Covid-19 without false-positives is possible using the right combi-nation of optimized solutions for ELISA protocol. more
It’s time to act if you are using alkylphenol ethoxylate (APE) surfactants such as nonylphenol ethoxylates (NPEs) and octylphenol ethoxylates (OPEs) more
Download free whitepaper ✓ Improve spatial resolution for 3D cell models ✓ Multiply throughput 20x ✓ Automatically apply compounds to living organoids more
It’s time to act if you are using alkylphenol ethoxylate (APE) surfactants such as nonylphenol ethoxylates (NPEs) and octylphenol ethoxylates (OPEs) more
Can the pharmaceutical industry digitize your processes as quickly as the current competitive situation requires? more
Mass flowmeters with Profinet allow automated processes to be monitored and to react in real time to alarms and error messages more
The quality and effectiveness of drugs significantly depends on their proper packaging: more
Microbial control is a major objective for all sterile drug manufacturers, with bioburden reduction representing a significant share of risk mitigation efforts more
© 1997-2020 LUMITOS AG, All rights reserved
